ASSANTO , Giovanni Manfredi et al. Impact of Sars-CoV-2 prophylaxis with tixagevimab-cilgavimab in high-risk patients with B-cell malignancies: a single-center retrospective study. Mediterranean Journal of Hematology and Infectious Diseases, [S. l.], v. 15, n. 1, p. e2023061, 2023. DOI: 10.4084/MJHID.2023.061. Disponível em: https://www.mjhid.org/mjhid/article/view/5415. Acesso em: 16 apr. 2024.